Partner Gardner Davis was quoted in a The Street article, “Peltz’s Battle Puts Spotlight on P&G’s Director Problem,” discussing investor Nelson Peltz and his activist attack on Procter & Gamble’s (P&G) board of directors.
Peltz is currently arguing that P&G’s directors are too overcommitted to devote attention to his campaign to join the board. According to BoardEx, P&G’s directors serve on average of 2.63 public boards, which is well above the average of 2.01 directorships for S&P 500 corporations.
Davis explained that although P&G’s directors “certainly have a lot of time commitments” because they serve on the boards for ‘A list’ companies, independent directors should serve on exactly two big public corporate boards if they want to maximize productivity. “Being on the boards of two different large cap board will help develop ideas. You will learn from the other directors and see how they react and bring those ideas to bear on company two,” he said.
The Street continues on by reporting that Peltz currently serves as a director for four other major public corporations and would likely need to step down in order to successfully serve on P&G’s. Davis commented on this by explaining “it is unfair to attack Peltz as overboarded because for him, this is his day job.”
Peltz is currently arguing that P&G’s directors are too overcommitted to devote attention to his campaign to join the board. According to BoardEx, P&G’s directors serve on average of 2.63 public boards, which is well above the average of 2.01 directorships for S&P 500 corporations.
Davis explained that although P&G’s directors “certainly have a lot of time commitments” because they serve on the boards for ‘A list’ companies, independent directors should serve on exactly two big public corporate boards if they want to maximize productivity. “Being on the boards of two different large cap board will help develop ideas. You will learn from the other directors and see how they react and bring those ideas to bear on company two,” he said.
The Street continues on by reporting that Peltz currently serves as a director for four other major public corporations and would likely need to step down in order to successfully serve on P&G’s. Davis commented on this by explaining “it is unfair to attack Peltz as overboarded because for him, this is his day job.”
People
Related News
25 July 2024
In the News
Donald Schroeder on Groff – ‘Supreme Court decision is inviting a more fact-based analysis’
Foley & Lardner LLP partner Donald Schroeder assessed the impact of the U.S. Supreme Court’s 2023 decision in a religious accommodation case as it returns to the district court in the Law360 article, “A Year After High Court Spotlight, Groff Case Still A Bellwether.”
24 July 2024
In the News
Louis Lehot Featured in Q&A on How Startups Can Prepare for IPO
Foley & Lardner LLP partner Louis Lehot features in the Q&A, "How startups can get in top shape for an IPO, according to Silicon Valley lawyer Louis Lehot," part of Business Insider's Road to IPO' series.
24 July 2024
In the News
Courtenay Brinckerhoff on Patent Cap in Drug Pricing – ‘Hard to predict if this will make a difference’
Foley & Lardner LLP partner Courtenay Brinckerhoff discussed a recent bill passed in the U.S. Senate aimed at lowering drug prices by limiting the number of patents that can be asserted in cases over biosimilars in the Law360 article, “Patent Cap In Drug Pricing Bill Seen As Having Muted Effect.”